Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
This study has been completed.
Sponsor:
Centre Val d'Aurelle - Paul Lamarque
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00559156
First received: November 15, 2007
Last updated: May 13, 2011
Last verified: May 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |